Reply To: NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs

Hematology Forums Hematology MCQ discussion forum NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs Reply To: NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs

#4207
thehematologist.orgthehematologist.org
Participant

Q51-60 = Based on adverse events of chemotherapeutic agents !

51. Which of the following is not a adverse event with L-Asparginase administration ?

[1] Pancreatitis
[2] Hepatitis
[3] Neuritis
[4] Hypersensitivity

52. Which of the following is implicated in increased thrombotic risk in ALL induction therapy ?

[1] L-Asparginase
[2] Prednisolone
[3] Both A and B
[4] None of these

53. Major dose limiting toxicity of vincristine ?

[1] Neutropenia
[2] Thrombocytopenia
[3] Neurotoxicity
[4] Diarrhoea

54. Which of the following is implicated in cardiotoxicity ?

[1] Vinblastine
[2] Doxorubicin
[3] L-Asparginase
[4] All of these

55. PRES during ALL induction therapy is attributed mainly as adverse effect of ?

[1] Prednisolone
[2] L-Asparginase
[3] Doxorubicin
[4] Vincristine